DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

NCT06329908 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhen-Yu Ding